产品封面图
文献支持

pCas9

收藏
  • ¥1180
  • LSM Bio
  • 进口
  • PVT6317
  • 2025年09月26日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      负20摄氏度

    • 保质期

      3个月

    • 英文名

      pCas9

    • 库存

      100

    • 供应商

      LSMBIO

    • 规格

      2ug

    pCas9

    Search name

    pCas9,Plasmid pCas9,pCas9 vector

     

    pCas9 Information

    Replicon: p15A ori

    Plasmid classification: Escherichia coli plasmids; Escherichia coli plasmids; large intestine Cas9 plasmids

    Plasmid size: 9326bp

    Prokaryotic resistance: chloramphenicol Chl (50 mu g/ml)

    Cloned strains of Escherichia coli, Stbl3 and other Escherichia coli

    Culture conditions: 37 centigrade, LB, aerobic

    Expression host: Escherichia coli

    Induction mode: no induction

    5'sequencing primers: StrepPyoCas9-5UTR-F (CGGTGCCACTTTTTCAAGTTG)

    3'sequencing primers: pBRrevBam (GGTGATGTCGGCGATATAGG)

    Use:CRISPR-CAS26-sgRNA plasmid

     

    pCas9 Description

    pCas9 plasmid is a CRISPR/Cas9 system carrier. The replicator is p15A ori and ori. The plasmid size is 9326bp, which can be transformed into the corresponding host cells. The mass raising condition is LB, 37 C.

    PCas9 can express Cas9 protein in Escherichia coli, and pCRISPR can be used for gene knockout, low copy plasmid, Bacterial expression of Cas9 nuclease, tracrRNA and crRNA and.

    PCas9 can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-baseddirected evolution, and combinatorial design. CRISPR-Cas9 nucleases enable efficient genome editing in a wide variety of organisms and cell types Target recognition by Cas9. Site is programmed by a chimeric single guide RNA (sgRNA) that encodes a sequence complementary to a target protospacer5, but a LSO requires recognition of a short neighboring PAM the most robust. SpCas9, and widely used Cas9 to date, primarily recognizes NGG PAMs and is consequently restricted to sites that contain this motif It therefore be challenging. Can to implement genome editing applications that require precision, such as: homology-directed repair (HDR), which is most efficient when DSBs are placed within BPS of a desired 10 - 20 alteration; the introduction of variable-length insertion or deletion (indel) mutations into small size genetic elements such as microRNAs, splice sites, short open reading frames, or transcription factor binding sites by non-homologous end-joining (NHEJ); and allele-specific editing, where PAM recognition might be exploited to Differentiate alleles.

     

    pCas9 Sequence

    LOCUS       Exported                9326 bp ds-DNA     circular SYN 28-JUN-2017
    DEFINITION  synthetic circular DNA
    KEYWORDS    pCas9
    SOURCE      synthetic DNA construct
      ORGANISM  synthetic DNA construct
    REFERENCE   1  (bases 1 to 9326)
      TITLE     Direct Submission
      JOURNAL   Exported Wednesday, June 28, 2017  
    FEATURES             Location/Qualifiers
         source          1..9326
                         /organism="synthetic DNA construct"
                         /mol_type="other DNA"
         promoter        complement(220..322)
                         /note="cat promoter"
                         /note="promoter of the E. coli cat gene encoding
                         chloramphenicol acetyltransferase"
         rep_origin      complement(848..1393)
                         /direction=LEFT
                         /note="p15A ori"
                         /note="Plasmids containing the medium-copy-number p15A
                         origin of replication can be propagated in E. coli cells
                         that contain a second plasmid with the ColE1 origin."
         promoter        1505..1533
                         /note="tet promoter"
                         /note="E. coli promoter for tetracycline efflux protein
                         gene"
         misc_RNA        complement(1851..1929)
                         /note="tracrRNA"
                         /note="trans-activating CRISPR RNA for the Streptococcus
                         pyogenes CRISPR/Cas9 system"
         CDS             2225..6331
                         /codon_start=1
                         /product="Cas9 (Csn1) endonuclease from the Streptococcus
                         pyogenes Type II CRISPR/Cas system"
                         /note="Cas9"
                         /note="generates RNA-guided double strand breaks in DNA"
                         /translation="MDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKK
                         NLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEES
                         FLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIK
                         FRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRL
                         ENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQ
                         IGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVR
                         QQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLL
                         RKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARG
                         NSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEY
                         FTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFD
                         SVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEER
                         LKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFM
                         QLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGR
                         HKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLY
                         LYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVP
                         SEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKH
                         VAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYL
                         NAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKT
                         EITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSK
                         ESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGI
                         TIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNE
                         LALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILAD
                         ANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVL
                         DATLIHQSITGLYETRIDLSQLGGD"
         misc_feature    6352..6483
                         /note="crRNA leader"
                         /note="crRNA leader sequence for the Streptococcus pyogenes
                         CRISPR/Cas system"
         repeat_region   6484..6519
                         /note="DR"
                         /note="direct repeat for the Streptococcus pyogenes
                         CRISPR/Cas system"
         repeat_region   6550..6585
                         /note="DR"
                         /note="direct repeat for the Streptococcus pyogenes
                         CRISPR/Cas system"
         CDS             complement(8886..219)
                         /codon_start=1
                         /gene="cat"
                         /product="chloramphenicol acetyltransferase"
                         /note="CmR"
                         /note="confers resistance to chloramphenicol"
                         /translation="MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFL
                         KTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSS
                         LWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANM
                         DNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA"
    ORIGIN
            1 gaattccgga tgagcattca tcaggcgggc aagaatgtga ataaaggccg gataaaactt
           61 gtgcttattt ttctttacgg tctttaaaaa ggccgtaata tccagctgaa cggtctggtt
          121 ataggtacat tgagcaactg actgaaatgc ctcaaaatgt tctttacgat gccattggga
          181 tatatcaacg gtggtatatc cagtgatttt tttctccatt ttagcttcct tagctcctga
          241 aaatctcgat aactcaaaaa atacgcccgg tagtgatctt atttcattat ggtgaaagtt
          301 ggaacctctt acgtgccgat caacgtctca ttttcgccaa aagttggccc agggcttccc
          361 ggtatcaaca gggacaccag gatttattta ttctgcgaag tgatcttccg tcacaggtat
          421 ttattcggcg caaagtgcgt cgggtgatgc tgccaactta ctgatttagt gtatgatggt
          481 gtttttgagg tgctccagtg gcttctgttt ctatcagctg tccctcctgt tcagctactg
          541 acggggtggt gcgtaacggc aaaagcaccg ccggacatca gcgctagcgg agtgtatact
          601 ggcttactat gttggcactg atgagggtgt cagtgaagtg cttcatgtgg caggagaaaa
          661 aaggctgcac cggtgcgtca gcagaatatg tgatacagga tatattccgc ttcctcgctc

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation Author:YangZhang1YiXu1WenyunLu23Jonathan M.Ghergurovich24LiliGuo56Ian A.Blair5Joshua D.Rabinowitz23XiaoluYang17 Received 22 January 2020, Revised 4 August 2020, Accepted 30 September 2020, Available online 6 November 2020. Published: November 6, 2020 Cell Metabolism Available online 6 November 2020 In Press doi: doi.org/10.1016/j.cmet.2020.10.002
    相关实验
    • 手把手教你学会 CRISPR Cas9 基因敲除技术

      μM)5μlNaCl 100 mM(终浓度)Tris‐Cl pH7.4 50 mM(终浓度)加水补足 50 μl将配制好的退火反应缓冲液重复混合,短暂离心后放置 PCR 仪上,运行以下程序: 90℃ 4 min, 70℃ 10 min, 55℃ 10 min, 40℃ 10 min, 25℃ 10 min。退火后的寡核苷酸可以立刻使用或者在 ‐20℃ 长期保存。三、   pCas9/gRNA 基因敲除载体的构建用 EcoRV 酶切 2 μg pCas9/gRNA 载体(inovogen)。通常

    • Luciferase Protein Complementation Assays for Bioluminescence Imaging of Cells and Mice

      Protein fragment complementation assays (PCAs) with luciferase reporters currently are the preferred method for detecting and quantifying protein–protein interactions in living animals. At the most basic level, PCAs involve fusion

    • CRISPR 技术进行细胞 TP53 基因敲除

      实验原理 TP53 是重要的抑癌基因。在多种肿瘤中都能发现 TP53 基因突变及功能丧失。我们将针对 TP53 基因设计的靶点构建到 pCas9/gRNA1 载体,转染 293T 细胞,构建了 TP53 基因敲除 293T 细胞系。 1、本实验基因敲除原理:pCas9/gRNA1 载体表达 gRNA 和 Cas9 蛋白。将靶点序列克隆到 pCas9/gRNA1 载体上,gRNA 将诱导 Cas9 蛋白对靶点 DNA 进行切割,造成 DNA 断裂。细胞通过邻端连接

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥800
    武汉维克赛思科技有限公司
    2025年09月20日询价
    ¥800
    上海钰博生物科技有限公司
    2025年07月15日询价
    ¥1
    上海联迈生物工程有限公司
    2025年07月13日询价
    ¥1200
    上海晶风生物科技有限公司
    2025年05月18日询价
    ¥680
    温州科淼生物科技有限公司
    2025年07月10日询价
    文献支持
    pCas9
    ¥1180